BSX - Company ID 0000885725
The table below shows BOSTON SCIENTIFIC CORP's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | $348.00M | $541.00M | $164.00M | $190.00M | -$58.00M | $284.00M |
| Capital expenditure | $177.00M | $187.00M | $179.00M | $111.00M | $121.00M | $75.00M |
| Investing cash flow | -$591.00M | -$500.00M | -$285.00M | -$484.00M | -$1.57B | $71.00M |
| Dividends paid | - | - | $0.00 | $14.00M |
BOSTON SCIENTIFIC CORP reported operating cash flow of $4.53B for fiscal year 2025. That is up 32.0% from $3.44B in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $1.18B (FY 2016) to $4.53B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $14.00M |
| $14.00M |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | -$260.00M | $233.00M | $1.57B | -$69.00M | -$6.00M | -$95.00M |